<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p44" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_44{left:130px;bottom:1195px;letter-spacing:0.22px;}
#t2_44{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_44{left:128px;bottom:1109px;letter-spacing:-0.18px;}
#t4_44{left:238px;bottom:1109px;letter-spacing:-0.21px;}
#t5_44{left:141px;bottom:1068px;letter-spacing:-0.1px;}
#t6_44{left:248px;bottom:1069px;letter-spacing:-0.01px;}
#t7_44{left:141px;bottom:1037px;letter-spacing:0.22px;}
#t8_44{left:250px;bottom:1032px;letter-spacing:-0.01px;}
#t9_44{left:250px;bottom:1012px;letter-spacing:-0.01px;}
#ta_44{left:250px;bottom:993px;letter-spacing:-0.01px;}
#tb_44{left:141px;bottom:989px;}
#tc_44{left:141px;bottom:957px;letter-spacing:-0.03px;}
#td_44{left:248px;bottom:957px;letter-spacing:-0.03px;}
#te_44{left:141px;bottom:910px;letter-spacing:-0.3px;}
#tf_44{left:248px;bottom:883px;letter-spacing:0.09px;}
#tg_44{left:238px;bottom:823px;letter-spacing:-0.01px;}
#th_44{left:238px;bottom:803px;letter-spacing:-0.01px;}
#ti_44{left:238px;bottom:784px;letter-spacing:-0.01px;}
#tj_44{left:238px;bottom:764px;letter-spacing:-0.01px;}
#tk_44{left:238px;bottom:745px;letter-spacing:-0.01px;}
#tl_44{left:477px;bottom:745px;letter-spacing:-0.01px;}
#tm_44{left:238px;bottom:726px;letter-spacing:-0.01px;}
#tn_44{left:238px;bottom:706px;letter-spacing:-0.01px;}
#to_44{left:238px;bottom:687px;letter-spacing:-0.01px;}
#tp_44{left:238px;bottom:667px;letter-spacing:-0.01px;}
#tq_44{left:238px;bottom:594px;letter-spacing:-0.01px;}
#tr_44{left:238px;bottom:574px;letter-spacing:-0.01px;}
#ts_44{left:238px;bottom:555px;letter-spacing:-0.01px;}
#tt_44{left:238px;bottom:535px;letter-spacing:-0.01px;}
#tu_44{left:238px;bottom:516px;letter-spacing:-0.01px;}
#tv_44{left:238px;bottom:497px;letter-spacing:-0.01px;}
#tw_44{left:238px;bottom:477px;letter-spacing:-0.01px;}
#tx_44{left:238px;bottom:458px;letter-spacing:-0.01px;}
#ty_44{left:238px;bottom:438px;letter-spacing:-0.01px;}
#tz_44{left:238px;bottom:419px;letter-spacing:-0.01px;}
#t10_44{left:238px;bottom:346px;letter-spacing:0.1px;}
#t11_44{left:238px;bottom:326px;letter-spacing:0.11px;}
#t12_44{left:238px;bottom:307px;letter-spacing:0.1px;}
#t13_44{left:238px;bottom:272px;letter-spacing:-0.01px;}
#t14_44{left:238px;bottom:252px;letter-spacing:-0.01px;}
#t15_44{left:238px;bottom:233px;letter-spacing:-0.01px;}
#t16_44{left:238px;bottom:213px;letter-spacing:-0.01px;}
#t17_44{left:238px;bottom:194px;letter-spacing:-0.01px;}
#t18_44{left:238px;bottom:174px;letter-spacing:-0.01px;}
#t19_44{left:238px;bottom:155px;letter-spacing:-0.01px;}
#t1a_44{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_44{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_44{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_44{font-size:18px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_44{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_44{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_44{font-size:8px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_44{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s7_44{font-size:10px;font-family:NotoSans-Regular_7j-;color:#000;}
.s8_44{font-size:9px;font-family:NotoSans-Regular_7j-;color:#000;}
.s9_44{font-size:13px;font-family:NotoSans-Regular_7j-_1;color:#000;}
.sa_44{font-size:12px;font-family:NotoSans-Regular_7j-_1;color:#000;}
.sb_44{font-size:11px;font-family:NotoSans-Regular_7j-_1;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts44" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

@font-face {
	font-family: NotoSans-Regular_7j-_1;
	src: url("fonts/NotoSans-Regular_7j-_1.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg44Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg44" style="-webkit-user-select: none;"><object width="908" height="1286" data="44/44.svg" type="image/svg+xml" id="pdf44" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_44" class="t s0_44">6.3. Imaging </span><span id="t2_44" class="t s1_44">44 </span>
<span id="t3_44" class="t s2_44">6.3.1. </span><span id="t4_44" class="t s2_44">PET-CT in laryngeal carcinoma </span>
<span id="t5_44" class="t s3_44">6.6. </span><span id="t6_44" class="t s4_44">Evidence-based recommendation </span>
<span id="t7_44" class="t s5_44">Recommendation level </span>
<span id="t8_44" class="t s4_44">After combined radio-chemotherapy, surveillance using FDG-PET-CT should be performed </span>
<span id="t9_44" class="t s4_44">in node-positive patients with laryngeal carcinoma (&gt;/=N2) as an alternative to planned </span>
<span id="ta_44" class="t s4_44">salvage neck dissection. </span>
<span id="tb_44" class="t s6_44">B </span>
<span id="tc_44" class="t s7_44">Level of Evidence </span><span id="td_44" class="t s7_44">[113-117] </span>
<span id="te_44" class="t s6_44">1b </span>
<span id="tf_44" class="t s8_44">Consensus: 82% </span>
<span id="tg_44" class="t s4_44">Imaging based purely on morphological information has certain limitations, for example in the </span>
<span id="th_44" class="t s4_44">detection of small carcinomas in clinically unremarkable organs. In this context, 18FDG PET/CT </span>
<span id="ti_44" class="t s4_44">has a significantly higher accuracy (sensitivity &gt; 95%) compared to staging with CT, MRI and </span>
<span id="tj_44" class="t s4_44">sonography [113, 118]. This can have a significant influence on the choice of treatment </span>
<span id="tk_44" class="t s4_44">regimen and thus also on the patient's </span><span id="tl_44" class="t s9_44">prognosis [119]. For example, Connel et al. [120] were </span>
<span id="tm_44" class="t s9_44">able to show that after performing 18FDG PET/CT as part of primary staging, up to 29% of </span>
<span id="tn_44" class="t s9_44">patients have a correction of the clinical TNM classification and thus a change in the treatment </span>
<span id="to_44" class="t s9_44">regimen [120]. 18FDG PET/CT even shows a higher detection rate of small carcinomas than </span>
<span id="tp_44" class="t s9_44">panendoscopy (6.1% vs. 4.5%). </span>
<span id="tq_44" class="t s9_44">PET/CT, on the other hand, only shows a sensitivity of 50% and a specificity of 87% in the </span>
<span id="tr_44" class="t s9_44">detection of clinically non-manifest lymph node metastases [121]. It is useful in preoperative </span>
<span id="ts_44" class="t s9_44">staging for the detection of clinically non-manifest lymph node metastases in addition to the </span>
<span id="tt_44" class="t s9_44">usual clinical examinations. Ozer et al. [117] found that PET/CT offers no advantage in the </span>
<span id="tu_44" class="t s9_44">diagnosis of clinical N0 neck. Minovi et al. [116] came to the same conclusion, finding that PET is </span>
<span id="tv_44" class="t s9_44">currently not unreservedly recommended for the pre-therapeutic evaluation of lymph node </span>
<span id="tw_44" class="t s9_44">metastases, although it appears to be superior to MRI in terms of the detection rate. Richard et </span>
<span id="tx_44" class="t s9_44">al. [115] also came to the conclusion that PET/CT has no reliable predictive value for the need </span>
<span id="ty_44" class="t s9_44">for neck dissection in clinical NO neck. They found false positive lymph node staging in 27% of </span>
<span id="tz_44" class="t s9_44">the levels and false negative lymph node staging in 12%. </span>
<span id="t10_44" class="t sa_44">In March 2017, the Federal Joint Committee decided in accordance with Section 91 of the Social </span>
<span id="t11_44" class="t sa_44">Code Book V that PET/CT is part of the standard service for head and neck tumors and can therefore </span>
<span id="t12_44" class="t sa_44">be used as an important diagnostic measure in specifically indicated cases. </span>
<span id="t13_44" class="t s9_44">If a metastasis is detected in a single lymph node of category N2b or N2c or an involved lymph </span>
<span id="t14_44" class="t s9_44">node measures more than 3 cm in maximum diameter (N2a or N3), there is a higher risk of </span>
<span id="t15_44" class="t s9_44">distant metastases. In this case, a whole-body FDG-PET-CT can be performed as an alternative </span>
<span id="t16_44" class="t s9_44">to CT of the thorax/abdomen to exclude or objectify distant metastases. (Sensitivity for the </span>
<span id="t17_44" class="t s9_44">detection of distant metastases 96.8%, specificity 95.4%, positive predictive value 69.8%, and </span>
<span id="t18_44" class="t s9_44">negative predictive value 99.6% [113]. However, some studies see no significant advantage of </span>
<span id="t19_44" class="t s9_44">PET/CT over CT [122-124] </span>
<span id="t1a_44" class="t sb_44">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
